Recently described mutations in the Kv1.1 pore domain (G376S, G396R, and G396V) provide evidence for the possibility of genetic modifiers altering the clinical presentations of KCNA1 channelopathy, especially with regard to epilepsy phenotypes. The gene discussed is KCNA1; the disease is channelopathy.